نتایج جستجو برای: lymphocyte associated antigen 4 ctla

تعداد نتایج: 2795929  

2013
Biao Jiang Meng Ji Ailiang Wang Wei Zhang Zhixin Zhang Qiang Li

Cytotoxic T-lymphocyte antigen 4 (CTLA-4) plays an important role in downregulating T cell activation and proliferation. The CTLA-4 +49G > A polymorphism is one of the most commonly studied polymorphisms in this gene due to its association with many cancer types, but the association between CTLA-4 +49G > A polymorphism and digestive system cancer risks remain inconclusive. An updated meta-analy...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2008
Jianda Yuan Sacha Gnjatic Hao Li Sarah Powel Humilidad F Gallardo Erika Ritter Geoffrey Y Ku Achim A Jungbluth Neil H Segal Teresa S Rasalan Gregor Manukian Yinyan Xu Ruth-Ann Roman Stephanie L Terzulli Melanie Heywood Evelina Pogoriler Gerd Ritter Lloyd J Old James P Allison Jedd D Wolchok

Blockade of inhibitory signals mediated by cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) has been shown to enhance T cell responses and induce durable clinical responses in patients with metastatic melanoma. The functional impact of anti-CTLA-4 therapy on human immune responses is still unclear. To explore this, we analyzed immune-related adverse events and immune responses in metastatic...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2003
F Stephen Hodi Martin C Mihm Robert J Soiffer Frank G Haluska Marcus Butler Michael V Seiden Thomas Davis Rochele Henry-Spires Suzanne MacRae Ann Willman Robert Padera Michael T Jaklitsch Sridhar Shankar Teresa C Chen Alan Korman James P Allison Glenn Dranoff

A large number of cancer-associated gene products evoke immune recognition, but host reactions rarely impede disease progression. The weak immunogenicity of nascent tumors contributes to this failure in host defense. Therapeutic vaccines that enhance dendritic cell presentation of cancer antigens increase specific cellular and humoral responses, thereby effectuating tumor destruction in some ca...

Journal: :Indian journal of forensic medicine and toxicology 2021

Graves’ disease (GD) is a multifactorial autoimmune with contribution from both genetic andepigenetic factors in its causation. Gene “protein tyrosine phosphatase non receptor 22” (PTPN22) animportant immune regulatory gene preventing hyper responsiveness of T cells by negatively regulatingtheir signal transduction. Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) polymorphisms belong to themain deter...

Journal: :Arthritis Research & Therapy 2007
Jacques-Eric Gottenberg Pascale Loiseau Mariam Azarian Chun Chen Nicolas Cagnard Eric Hachulla Xavier Puechal Jean Sibilia Dominique Charron Xavier Mariette Corinne Miceli-Richard

CTLA-4 encodes cytotoxic T lymphocyte-associated antigen-4, a cell-surface molecule providing a negative signal for T-cell activation. CTLA-4 gene polymorphisms have been widely studied in connection with genetic susceptibility to various autoimmune diseases, but studies have led to contradictory results in different populations. This case-control study sought to investigate whether CTLA-4 CT60...

Journal: :Current Biology 1996
Peter S Linsley Pierre Golstein

The initiation of immune responses usually requires interactions of T lymphocytes with antigen-presenting cells. The specificity of these interactions depends on the recognition by the T cell’s antigen receptor of an antigenic peptide presented in a complex with molecules of the major histocompatibility complex (MHC). But a successful immune response requires additional costimulation of the T c...

2014
Xiaozhou Fan Sergio A. Quezada Manuel A. Sepulveda Padmanee Sharma James P. Allison

Cytotoxic T lymphocyte antigen-4 (CTLA-4) blockade with a monoclonal antibody yields durable responses in a subset of cancer patients and has been approved by the FDA as a standard therapy for late-stage melanoma. We recently identified inducible co-stimulator (ICOS) as a crucial player in the antitumor effects of CTLA-4 blockade. We now show that concomitant CTLA-4 blockade and ICOS engagement...

Central ossifying fibroma is a benign, slow-growing tumor of mesenchymal origin with a predilection for the mandibular premolar and molar areas. The immunophenotype of T cells involved in the antitumor response against this benign tumor is unknown. In this case report, we described a case of a 48-year-old woman presenting with a very large recurrent ossifying fibroma in the mandible, which was ...

2009
Randall H. Friedline David S. Brown Hai Nguyen Hardy Kornfeld JinHee Lee Yi Zhang Mark Appleby Sandy D. Der Joonsoo Kang Cynthia A. Chambers

Cytotoxic T lymphocyte antigen-4 (CTLA-4) plays a critical role in negatively regulating T cell responses and has also been implicated in the development and function of natural FOXP3(+) regulatory T cells. CTLA-4-deficient mice develop fatal, early onset lymphoproliferative disease. However, chimeric mice containing both CTLA-4-deficient and -sufficient bone marrow (BM)-derived cells do not de...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2016
Katrin Klocke Shimon Sakaguchi Rikard Holmdahl Kajsa Wing

Cytotoxic T lymphocyte antigen-4 (CTLA-4) is essential for immunological (self-) tolerance, but due to the early fatality of CTLA-4 KO mice, its specific function in central and peripheral tolerance and in different systemic diseases remains to be determined. Here, we further examined the role of CTLA-4 by abrogating CTLA-4 expression in adult mice and compared the resulting autoimmunity that f...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید